Related references
Note: Only part of the references are listed.miRNAs in melanoma: a defined role in tumor progression and metastasis
Francesco Mannavola et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Germline TERT promoter mutations are rare in familial melanoma
Mark Harland et al.
FAMILIAL CANCER (2016)
Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF
J. Cisowski et al.
ONCOGENE (2016)
TET2 Negatively Regulates Nestin Expression in Human Melanoma
Camilla B. F. Gomes et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo
P. Tschandl et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations
Lavinia Spain et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Emerging roles of lncRNAs in senescence
Marta Montes et al.
FEBS JOURNAL (2016)
Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival
Mi Ryung Roh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Association of TERT promoter mutations with telomerase expression in melanoma
Seungjae Lee et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs)
Andrew M. Kidger et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Blue nevus and malignant blue nevus: A concise review
Jessica Zarah Sugianto et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2016)
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR
Goran Micevic et al.
CELL REPORTS (2016)
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
Yuliya V. Katlinskaya et al.
CELL REPORTS (2016)
Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas
Holger A. Haenssle et al.
JAMA DERMATOLOGY (2016)
Study of the Immunophenotype of the Inflammatory Cells in Melanomas With Regression and Halo Nevi
Rafael Botella-Estrada et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2015)
The unfolded protein response and cellular senescence. A Review in the Theme: Cellular Mechanisms of Endoplasmic Reticulum Stress Signaling in Health and Disease
Olivier Pluquet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Mutational status of naevus-associated melanomas
D. Shitara et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation
William Damsky et al.
CANCER CELL (2015)
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets
Marzia Scortegagna et al.
CANCER RESEARCH (2015)
p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis
Xuyi Wang et al.
CANCER RESEARCH (2015)
Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase
Yoshiko Maida et al.
CANCER SCIENCE (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
ER stress-induced autophagy in melanoma
Xiao-Xiao Meng et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
Update on melanocytic nevi in children
Julie V. Schaffer
CLINICS IN DERMATOLOGY (2015)
Epigenetic regulation in human melanoma: past and future
Debina Sarkar et al.
EPIGENETICS (2015)
Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
Helena Populo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma
Josephine Vagner et al.
HISTOPATHOLOGY (2015)
BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations
Adrian Pins et al.
HUMAN PATHOLOGY (2015)
Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia
Jerry D. Brewer et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
Cheryl M. Koh et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
Hansje-Eva Teulings et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations
Nemanja Rodic et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2015)
eIF4E Is an Adverse Prognostic Marker of Melanoma Patient Survival by Increasing Melanoma Cell Invasion
Shahram Khosravi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Melanoma Risk and Survival among Organ Transplant Recipients
Hilary A. Robbins et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
mTOR in health and in sickness
Dritan Liko et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Outcome of patients with de novo versus nevus-associated melanoma
William M. Lin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma
Shannon Famenini et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
Nicholas Theodosakis et al.
MOLECULAR CANCER THERAPEUTICS (2015)
MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype
Hongshan Chen et al.
MOLECULAR CELL (2015)
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nicolas Herranz et al.
NATURE CELL BIOLOGY (2015)
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
Remi-Martin Laberge et al.
NATURE CELL BIOLOGY (2015)
The Genetic Evolution of Melanoma from Precursor Lesions
A. Hunter Shain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genetics of familial melanoma: 20 years after CDKN2A
Lauren G. Aoude et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Genetics of melanocytic nevi
Mi Ryung Roh et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
High burden and pervasive positive selection of somatic mutations in normal human skin
Inigo Martincorena et al.
SCIENCE (2015)
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Cristian Tomasetti et al.
SCIENCE (2015)
Molecular drivers of cellular metabolic reprogramming in melanoma
Cecilie Abildgaard et al.
TRENDS IN MOLECULAR MEDICINE (2015)
The lncRNA MIR31HG regulates p16INK4A expression to modulate senescence
Marta Montes et al.
NATURE COMMUNICATIONS (2015)
RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma
Florence Laugier et al.
ONCOTARGET (2015)
DNA-Damage-Induced Type I Interferon Promotes Senescence and Inhibits Stem Cell Function
Qiujing Yu et al.
CELL REPORTS (2015)
BRAF Wild-Type Melanoma in Situ Arising In a BRAF V600E Mutant Dysplastic Nevus
Jean-Marie Tan et al.
JAMA DERMATOLOGY (2015)
The macrophage: Switches from a passenger to a driver during anticancer therapy
Tao Wang et al.
ONCOIMMUNOLOGY (2015)
The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
Emanuela Romano et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Claudin11 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin, but Uncommon in Nevus Cell Nevi
Sara K. Walesch et al.
CANCERS (2015)
Melanoma: from incurable beast to a curable bet. The success of immunotherapy
Maria Libera Ascierto et al.
FRONTIERS IN ONCOLOGY (2015)
Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma
Lauren G. Aoude et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
County-level association of melanoma and papillary thyroid cancer: evidence of shared environmental risk?
Jason P. Lott et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Nevus-Associated Melanomas: Clinicopathologic Features
Danielle Shitara et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
BRAF Analysis on a Spectrum of Melanocytic Neoplasms: An Epidemiological Study Across Differing UV Regions
Maya Saroufim et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2014)
The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
Boris C. Bastian
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways
A. Slominski et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Autophagy suppresses melanoma tumorigenesis by inducing senescence
He Liu et al.
AUTOPHAGY (2014)
Heparan sulfate proteoglycans and heparin regulate melanoma cell functions
D. Nildtovic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
ARF tumor suppression in the nucleouls
Leonard B. Maggi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Prevalence of actinic keratosis among dermatology outpatients in Austria
J. Eder et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
The developing story of Sprouty and cancer
Samar Masoumi-Moghaddam et al.
CANCER AND METASTASIS REVIEWS (2014)
TERT promoter mutations in cancer development
Barbara Heidenreich et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Diminished WNT → β-catenin → c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors
Joseph Juan et al.
GENES & DEVELOPMENT (2014)
Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma
Xiao-Hong Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Melanoma Patients under Vemurafenib: Prospective Follow-Up of Melanocytic Lesions by Digital Dermoscopy
Marie Perier-Muzet et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy
Linda Gao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
The deep penetrating nevus
Lauren Strazzula et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
The Molecular Balancing Act of p16INK4a in Cancer and Aging
Kyle M. LaPak et al.
MOLECULAR CANCER RESEARCH (2014)
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
Diletta Di Mitri et al.
NATURE (2014)
Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression
Yoonjin Lee et al.
NATURE (2014)
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53
Amaya Viros et al.
NATURE (2014)
POT1 loss-of-function variants predispose to familial melanoma
Carla Daniela Robles-Espinoza et al.
NATURE GENETICS (2014)
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
Jianxin Shi et al.
NATURE GENETICS (2014)
Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of BrafV600E::Pten-/- melanoma
M. Scortegagna et al.
ONCOGENE (2014)
Melanoma metastasis: new concepts and evolving paradigms
W. E. Damsky et al.
ONCOGENE (2014)
Three-dimensional modelling for estimation of nevus count and probability of nevus-melanoma progression in a murine model
Eric Chai et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients
Taro Masaki et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
G12DNRAS and kinase-dead BRAF cooperate to drive naevogenesis and melanomagenesis
Malin Pedersen et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas
Hojabr Kakavand et al.
PATHOLOGY (2014)
mTORC2 in the center of cancer metabolic reprogramming
Kenta Masui et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
BRAFV600E Mutation Status of Involuting and Stable Nevi in Dabrafenib Therapy With or Without Trametinib
Phil McClenahan et al.
JAMA DERMATOLOGY (2014)
Inside and out: the activities of senescence in cancer
Pedro A. Perez-Mancera et al.
NATURE REVIEWS CANCER (2014)
Epigenetic Modifications in Cutaneous Malignant Melanoma
Panagiotis Kampilafkos et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2013)
Nevic Mitoses: A Review of 1041 Cases
Emily A. O'Rourke et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2013)
Predictors of BRAF Mutation in Melanocytic Nevi: Analysis Across Regions With Different UV Radiation Exposure
Sarah Karram et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2013)
Depletion of Deoxyribonucleotide Pools Is an Endogenous Source of DNA Damage in Cells Undergoing Oncogene-Induced Senescence
Sudha Mannava et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Aging, Cellular Senescence, and Cancer
Judith Campisi
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
Francisca Vazquez et al.
CANCER CELL (2013)
Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
Rizwan Haq et al.
CANCER CELL (2013)
Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases
F. Libon et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)
Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo
S. Sanchez-Sosa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Spitz Nevus, Spitz Tumor, and Spitzoid Melanoma: A Comprehensive Clinicopathologic Overview
Gerardo Ferrara et al.
DERMATOLOGIC CLINICS (2013)
Lysosome-mediated processing of chromatin in senescence
Andre Ivanov et al.
JOURNAL OF CELL BIOLOGY (2013)
HIF1α and HIF2α independently activate SRC to promote melanoma metastases
Sara C. Hanna et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Alexandre Iannello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Clonal BRAF Mutations in Melanocytic Nevi and Initiating Role of BRAF in Melanocytic Neoplasia
Iwei Yeh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Joanna Kaplon et al.
NATURE (2013)
p53 status determines the role of autophagy in pancreatic tumour development
Mathias T. Rosenfeldt et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta et al.
NATURE CELL BIOLOGY (2013)
JARID1B expression in human melanoma and benign melanocytic skin lesions
Lukasz Kuzbicki et al.
MELANOMA RESEARCH (2013)
NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi
Philipp Tschandl et al.
PLOS ONE (2013)
Oncogene-induced cellular senescence elicits an anti-Warburg effect
Mingxi Li et al.
PROTEOMICS (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Telomere Dynamics in Mice and Humans
Rodrigo T. Calado et al.
SEMINARS IN HEMATOLOGY (2013)
Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence
Katherine M. Aird et al.
CELL REPORTS (2013)
Eruptive Melanocytic Nevi in a Patient Undergoing Treatment With Sunitinib
David Jimenez-Gallo et al.
JAMA DERMATOLOGY (2013)
Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
Y. Xu et al.
BRITISH JOURNAL OF CANCER (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Christine Guo Lian et al.
CELL (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Oncogene-induced senescence results in marked metabolic and bioenergetic alterations
Celia Quijano et al.
CELL CYCLE (2012)
Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
Marina Kolesnichenko et al.
CELL CYCLE (2012)
Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome
Rossitza Lazova et al.
CLINICAL CANCER RESEARCH (2012)
Update on Immunohistochemistry in Melanocytic Lesions
Tammie Ferringer
DERMATOLOGIC CLINICS (2012)
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions
Anitha Suram et al.
EMBO JOURNAL (2012)
A blueprint for staging of murine melanocytic lesions based on the Cdk4R24C/R24C::Tyr-NRASQ61K model
Elisabeth M. T. Wurm et al.
EXPERIMENTAL DERMATOLOGY (2012)
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
Liesbeth C. W. Vredeveld et al.
GENES & DEVELOPMENT (2012)
Marked, Homogeneous, and Early [18F]Fluorodeoxyglucose-Positron Emission Tomography Responses to Vemurafenib in BRAF-Mutant Advanced Melanoma
Grant A. McArthur et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
RASSF10 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin but Uncommon in Nevus Cell Nevi
Peter Helmbold et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi
Sieu L. Tran et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
The natural history of halo nevi: A retrospective case series
Mouhammad Aouthmany et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
The dysplastic nevus: From historical perspective to management in the modern era
Keith Duffy et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Loss of microRNA-205 expression is associated with melanoma progression
Shujing Liu et al.
LABORATORY INVESTIGATION (2012)
Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation
Marzia Fumagalli et al.
NATURE CELL BIOLOGY (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines
Brenden Chen et al.
PLOS ONE (2012)
IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors
Valentina Evdokimova et al.
SCIENCE SIGNALING (2012)
Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence
Graeme Hewitt et al.
NATURE COMMUNICATIONS (2012)
Cancer Cell Metabolism: One Hallmark, Many Faces
Jason R. Cantor et al.
CANCER DISCOVERY (2012)
Variables Predicting Change in Benign Melanocytic Nevi Undergoing Short-term Dermoscopic Imaging
Scott W. Menzies et al.
ARCHIVES OF DERMATOLOGY (2011)
β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
William E. Damsky et al.
CANCER CELL (2011)
Autophagy: Renovation of Cells and Tissues
Noboru Mizushima et al.
CELL (2011)
Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development
Assaf C. Bester et al.
CELL (2011)
A Decade of Melanomas: Identification of Factors Associated with Delayed Detection in an Academic Group Practice
Agnessa Gadeliya Goodson et al.
DERMATOLOGIC SURGERY (2011)
Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma: An immunohistochemical study and analysis of prognostic value
Junna Oba et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
Alyssa L. Kennedy et al.
MOLECULAR CELL (2011)
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
Craig J. Ceol et al.
NATURE (2011)
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Tae-Won Kang et al.
NATURE (2011)
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3
Stuart MacGregor et al.
NATURE GENETICS (2011)
DNA-methylation profiling distinguishes malignant melanomas from benign nevi
Kathleen Conway et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes
Masako Narita et al.
SCIENCE (2011)
Frequent Mitotic Activity in Banal Melanocytic Nevi Uncovered by Immunohistochemical Analysis
Katharina Glatz et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2010)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
Lyndee L. Scurr et al.
CELL (2010)
Role for IGFBP7 in Senescence Induction by BRAF
Narendra Wajapeyee et al.
CELL (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Comparative Analysis of Total Body and Dermatoscopic Photographic Monitoring of Nevi in Similar Patient Populations at Risk for Cutaneous Melanoma
Agnessa Gadeliya Goodson et al.
DERMATOLOGIC SURGERY (2010)
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
Maria Berdasco et al.
DEVELOPMENTAL CELL (2010)
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Clelia Miracco et al.
HUMAN PATHOLOGY (2010)
Melanocytic nevi in pregnancy: histologic features and Ki-67 proliferation index
May P. Chan et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2010)
Autophagy in cutaneous malignant melanoma
Rossitza Lazova et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2010)
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
Avnish Kapoor et al.
NATURE (2010)
A role for the JARID1B stem cell marker for continuous melanoma growth
Matthew Held et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis
O. E. Dadzie et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Nathalie Dhomen et al.
CANCER CELL (2009)
Autophagy mediates the mitotic senescence transition
Andrew R. J. Young et al.
GENES & DEVELOPMENT (2009)
Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma
Liquing Zhuang et al.
HISTOPATHOLOGY (2009)
Reduced p16 and Increased Cyclin D1 and pRb Expression Are Correlated With Progression in Cutaneous Melanocytic Tumors
Rooshdiya Z. Karim et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2009)
The Absence of BRAF, FGFR3, and PIK3CA Mutations Differentiates Lentigo Simplex from Melanocytic Nevus and Solar Lentigo
Christian Hafner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor Suppressors
Sebastian Haferkamp et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression
Roy King et al.
MODERN PATHOLOGY (2009)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi
Mario Falchi et al.
NATURE GENETICS (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Spontaneous regression of metastases from melanoma: review of the literature
Louise Vennegaard Kalialis et al.
MELANOMA RESEARCH (2009)
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice
V. K. Goel et al.
ONCOGENE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions
Michel R. Nasr et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2008)
Melanoma in organ transplant recipients: Clinicopathological features and outcome in 100 cases
R. N. Matin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Akt and mutant V600EB-Raf cooperate to promote early melanoma development
Mitchefl Cheung et al.
CANCER RESEARCH (2008)
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network
Thomas Kuilman et al.
CELL (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Expression of γ-H2AX in melanocytic lesions
Matthew J. Wasco et al.
HUMAN PATHOLOGY (2008)
MTOR is activated in the majority of malignant melanomas
Magdalena Karbowniczek et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
D. Zhuang et al.
ONCOGENE (2008)
BRAFE600 in benign and malignant human tumours
C. Michaloglou et al.
ONCOGENE (2008)
Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi
Debdutta Bandyopadhyay et al.
AGING CELL (2007)
Expression of activated Akt in benign nevi, Spitz nevi and melanomas
Sara M. Kantrow et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
Silvina Gazzaniga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo
Veronique Bataille et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Melanocytic skin lesions and pregnancy: digital dermoscopy analysis
Pietro Rubegni et al.
SKIN RESEARCH AND TECHNOLOGY (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Epigenetic silencing of novel tumor suppressors in malignant melanoma
Viswanathan Muthusamy et al.
CANCER RESEARCH (2006)
A negative feedback signaling network underlies oncogene-induced senescence
Stephanie Courtois-Cox et al.
CANCER CELL (2006)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al.
NATURE (2006)
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway
Christophe Denoyelle et al.
NATURE CELL BIOLOGY (2006)
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
V. C. Gray-Schopfer et al.
BRITISH JOURNAL OF CANCER (2006)
BRAF and NRAS mutations in melanoma and melanocytic nevi
Jenny N. Poynter et al.
MELANOMA RESEARCH (2006)
Mechanisms of disease - Melanoma
Arlo J. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Senescence-associated β-galactosidase is lysosomal β-galactosidase
BY Lee et al.
AGING CELL (2006)
Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions
MR Hussein et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Implication of MT1-MMP in the maturation steps of benign melanocytic nevi
LJ Pérez et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2006)
Ultraviolet radiation at places of residence and the development of melanocytic nevi in children (Australia)
DR English et al.
CANCER CAUSES & CONTROL (2006)
Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi
Pablo Uribe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Cutaneous melanoma susceptibility and progression genes
FA de Snoo et al.
CANCER LETTERS (2005)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma
L Zhuang et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi
T Papp et al.
MELANOMA RESEARCH (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases
DL Dai et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
EE Patton et al.
CURRENT BIOLOGY (2005)
Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi
SR Florell et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2005)
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
S Gandini et al.
EUROPEAN JOURNAL OF CANCER (2005)
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma
H Tsao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Longitudinal assessment of the nevus phenotype in a melanoma kindred
SR Florell et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT
AM Mirza et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Deregulated Akt3 activity promotes development of malignant melanoma
JM Stahl et al.
CANCER RESEARCH (2004)
Cutaneous melanomas associated with nevi
C Bevona et al.
ARCHIVES OF DERMATOLOGY (2003)
Eruptive melanocytic nevi in patients with renal allografts: Report of 10 cases with dermoscopic findings
M Alaibac et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
A DNA damage checkpoint response in telomere-initiated senescence
FD di Fagagna et al.
NATURE (2003)
Grading of atypia in nevi: Correlation with melanoma risk
M Arumi-Uria et al.
MODERN PATHOLOGY (2003)
Association of increased autophagic inclusions labeled for β-galactosidase with fibroblastic aging
LM Gerland et al.
EXPERIMENTAL GERONTOLOGY (2003)
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
M Narita et al.
CELL (2003)
Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data
J Bauer et al.
PIGMENT CELL RESEARCH (2003)
Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer
BC Bastian
ONCOGENE (2003)
Hypothesis: A role for telomere crisis in spontaneous regression of melanoma
BC Bastian
ARCHIVES OF DERMATOLOGY (2003)
Early melanoma detection: Nonuniform dermoscopic features and growth
CR Lucas et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Melanoma ex naevo:: a study of the associated naevus
I Bogdan et al.
MELANOMA RESEARCH (2003)
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma - A population-based estimate
H Tsao et al.
ARCHIVES OF DERMATOLOGY (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma
H Tsao et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
PTEN/MMACl expression in melanoma resection specimens
M Deichmann et al.
BRITISH JOURNAL OF CANCER (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma
DC Whiteman et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity
C Miracco et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma
A Demunter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi
G Annessi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Assessment of clonality in melanocytic nevi
P Hui et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2001)
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
GM Kraehn et al.
BRITISH JOURNAL OF CANCER (2001)
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation
XP Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features
BC Bastian et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Telomerase activity in melanocytic lesions -: A potential marker of tumor biology
P Rudolph et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Melanocytic nevus with pregnancy-related changes in size accompanied by apoptosis of nevus cells: A case report
HJ Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Frequency and characteristics of enlarging common melanocytic nevi
H Kittler et al.
ARCHIVES OF DERMATOLOGY (2000)
TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas
S Lyle et al.
MODERN PATHOLOGY (2000)
Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
JAN Bishop et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
